Secondary BRCA1/2 mutations are associated with platinum resistance in BRCA1/2-mutated ovarian carcinomas

被引：0
|
作者：
Norguist, B. [1 ]
Taniguchi, T. [1 ]
Wurz, K. [1 ]
Karlan, B. [1 ]
Villegas, E. [1 ]
Sakai, W. [1 ]
Swisher, E. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
D O I：
10.1016/j.ygyno.2009.10.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：594 / 594
页数：1
相关论文
共 50 条
  • [1] Secondary BRCA1/2 mutations are associated with platinum resistance in a large series of BRCA1/2-mutated ovarian carcinomas
    Norquist, B.
    Sakai, W.
    Wurz, K.
    Karlan, B.
    Taniguchi, T.
    Swisher, E.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S4 - S4
  • [2] Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
    Swisher, Elizabeth M.
    Sakai, Wataru
    Karlan, Beth Y.
    Wurz, Kaitlyn
    Urban, Nicole
    Taniguchi, Toshiyasu
    [J]. CANCER RESEARCH, 2008, 68 (08) : 2581 - 2586
  • [3] BRCA1/2 reversion mutations as a mechanism of acquired drug resistance in BRCA1/2-mutated cancers
    Taniguchi, Toshiyasu
    [J]. CANCER SCIENCE, 2023, 114 : 260 - 260
  • [4] GENOMICS OF BRCA1/2-MUTATED BREAST CANCERS
    Jonkers, J.
    [J]. CELLULAR ONCOLOGY, 2010, 32 (03): : 162 - 162
  • [5] Secondary mutations of BRCA1/2 and drug resistance
    Dhillon, Kiranjit K.
    Swisher, Elizabeth M.
    Taniguchi, Toshiyasu
    [J]. CANCER SCIENCE, 2011, 102 (04): : 663 - 669
  • [6] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    [J]. CANCER RESEARCH, 2016, 76
  • [7] Responses to carboplatin in BRCA1/2-mutated breast cancer
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2018, 19 (07): : E337 - E337
  • [8] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [9] Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
    Norquist, Barbara
    Wurz, Kaitlyn A.
    Pennil, Christopher C.
    Garcia, Rochelle
    Gross, Jenny
    Sakai, Wataru
    Karlan, Beth Y.
    Taniguchi, Toshiyasu
    Swisher, Elizabeth M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) : 3008 - 3015
  • [10] PD-1, PD-L1 in BRCA1/2-mutated and non-mutated epithelial ovarian carcinomas (EOCs).
    Sachdev, Jasgit C.
    Arguello, David
    Abbott, Brian L.
    Reddy, Sandeep K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345